X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
index medicus (19) 19
breast cancer (18) 18
female (18) 18
oncology (15) 15
cancer (14) 14
middle aged (14) 14
breast neoplasms - pathology (12) 12
adult (11) 11
aged (11) 11
breast neoplasms - drug therapy (9) 9
chemotherapy (9) 9
breast neoplasms - genetics (8) 8
tumors (8) 8
analysis (7) 7
care and treatment (7) 7
medicine & public health (7) 7
chemotherapy, adjuvant (6) 6
research (6) 6
surgery (6) 6
breast (5) 5
diagnosis (5) 5
metastasis (5) 5
risk assessment (5) 5
treatment outcome (5) 5
women (5) 5
disease-free survival (4) 4
health aspects (4) 4
internal medicine (4) 4
life sciences (4) 4
mutation (4) 4
neoadjuvant therapy (4) 4
neoplasm staging (4) 4
pathology (4) 4
prognosis (4) 4
radiology, nuclear medicine & medical imaging (4) 4
adjuvant treatment (3) 3
age (3) 3
aged, 80 and over (3) 3
algorithms (3) 3
anthracyclines (3) 3
antineoplastic agents (3) 3
antineoplastic agents - therapeutic use (3) 3
biopsy (3) 3
breast neoplasms - diagnosis (3) 3
breast neoplasms - mortality (3) 3
cancer therapies (3) 3
carcinoma (3) 3
clinical trials (3) 3
diagnostic radiology (3) 3
erbb-2 protein (3) 3
follow-up studies (3) 3
france (3) 3
genetic aspects (3) 3
hematology, oncology and palliative medicine (3) 3
imaging / radiology (3) 3
interventional radiology (3) 3
medical prognosis (3) 3
metastases (3) 3
neoadjuvant chemotherapy (3) 3
neuroradiology (3) 3
patients (3) 3
predictive value of tests (3) 3
prospective studies (3) 3
retrospective studies (3) 3
risk (3) 3
risk factors (3) 3
survival (3) 3
survival analysis (3) 3
time factors (3) 3
trastuzumab (3) 3
ultrasound (3) 3
womens health (3) 3
young adult (3) 3
[sdv.can]life sciences [q-bio]/cancer (2) 2
abridged index medicus (2) 2
animals (2) 2
antimitotic agents (2) 2
antineoplastic agents - adverse effects (2) 2
benign (2) 2
biochemistry & molecular biology (2) 2
biomarkers, tumor - metabolism (2) 2
biopsy, fine-needle (2) 2
brca1 (2) 2
breast - pathology (2) 2
breast density (2) 2
breast neoplasms - diagnostic imaging (2) 2
breast neoplasms - epidemiology (2) 2
breast-cancer (2) 2
cancer patients (2) 2
carcinoma, ductal, breast - genetics (2) 2
carriers (2) 2
cell biology (2) 2
clinical-trials (2) 2
cohort studies (2) 2
confidence intervals (2) 2
cyclophosphamide (2) 2
dendritic cells (2) 2
density (2) 2
deoxyribonucleic acid--dna (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 4, pp. 445 - 452
Objectives This study sought to investigate long-term cardiovascular mortality and its relationship to the use of radiotherapy for breast cancer. Background... 
Cardiovascular | Internal Medicine | causes of death | long-term mortality | long-term risk | radiotherapy | breast cancer | cardiac disease | cardiovascular diseases | International Classification of Diseases | ICD | Institut Gustave Roussy | IGR | internal mammary chain | IMC | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | RISK | CARDIAC MORTALITY | RADIATION-THERAPY | LUNG-CANCER | HEART-DISEASE | MORBIDITY | ADJUVANT RADIOTHERAPY | IONIZING-RADIATION | SURVIVORS | Follow-Up Studies | Radiation Injuries - mortality | Humans | Middle Aged | Cause of Death | Time Factors | Heart - radiation effects | Cardiovascular Diseases - mortality | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | France | Radiotherapy, Adjuvant | Mastectomy, Segmental - methods | Radiotherapy Dosage | Cardiovascular Diseases - etiology | Risk Assessment | Cancer Care Facilities | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Survival Analysis | Breast Neoplasms - mortality | Aged | Cohort Studies | Breast cancer | Radiotherapy | Health aspects | Epidemiology | Mortality | Heart | Medical records | Cardiovascular disease | Statistical methods | Histology | Radiation therapy | Multivariate analysis | Cancer therapies | Patients | Survival analysis | Womens health | Surgery | Medical prognosis | Age
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 4, pp. 381 - 390
Summary Background Gene-expression arrays have generated molecular predictors of relapse and drug sensitivity in breast cancer. We aimed to identify exons... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PROGNOSIS | LOGISTIC-REGRESSION | BIOPSY | GENE-EXPRESSION | CARCINOMAS | CLASSIFICATION | SPLICING-SENSITIVE MICROARRAYS | TUMORS | NEEDLE-ASPIRATION-CYTOLOGY | PACLITAXEL | Carcinoma, Ductal, Breast - genetics | Carcinoma, Papillary - genetics | Prognosis | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoma, Intraductal, Noninfiltrating - genetics | Gene Expression Profiling | RNA, Messenger - metabolism | Carcinoma, Papillary - secondary | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Carcinoma, Lobular - genetics | Neoplasms - genetics | RNA Splicing - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | RNA, Messenger - genetics | Carcinoma, Papillary - drug therapy | Exons - genetics | Treatment Outcome | Carcinoma, Intraductal, Noninfiltrating - drug therapy | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Biopsy, Fine-Needle | Breast Neoplasms - genetics | Validation Studies as Topic | Breast Neoplasms - pathology | Adolescent | Aged | Biomarkers, Tumor - genetics | Carcinoma, Lobular - drug therapy | Neoplasm Staging | Neoplasms - pathology | Carcinoma, Intraductal, Noninfiltrating - secondary | Analysis | Breast cancer
Journal Article
Human Pathology, ISSN 0046-8177, 2012, Volume 43, Issue 11, pp. 1932 - 1939
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 12, pp. 1578 - 1586
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
Nature medicine, ISSN 1078-8956, 11/2014, Volume 20, Issue 11, pp. 1301 - 1309
Some of the anti-neoplastic effects of anthracyclines in mice originate from the induction of innate and T cell-mediated anticancer immune responses. Here we... 
MEDICINE, RESEARCH & EXPERIMENTAL | DOUBLE-STRANDED-RNA | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNATE | RIG-I | TUMORS | CELL BIOLOGY | TOLL-LIKE RECEPTOR-3 | BREAST-CANCER | ANTICANCER CHEMOTHERAPY | GENE | IMMUNE-RESPONSES | Doxorubicin - therapeutic use | Breast Neoplasms - immunology | Humans | RNA, Messenger - metabolism | Adaptor Proteins, Vesicular Transport - metabolism | Interferon Type I - biosynthesis | Receptors, Pattern Recognition - metabolism | Neoplasm Metastasis | Anthracyclines - pharmacology | Interferon Type I - metabolism | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | RNA - metabolism | Receptor, Interferon alpha-beta - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Treatment Outcome | Toll-Like Receptor 3 - metabolism | Breast Neoplasms - drug therapy | Animals | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Immunocompetence - drug effects | Anthracyclines - therapeutic use | Chemokine CXCL10 - metabolism | Myxovirus Resistance Proteins - metabolism | Doxorubicin - pharmacology | Anthracyclines | Care and treatment | Analysis | Physiological aspects | Interferon | Research | Cancer | Signal transduction | Chemotherapy | Breast cancer | Chemokines | Life Sciences | Immunology | Immunotherapy
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 05/2019, Volume 21, Issue 1, pp. 65 - 14
BackgroundHeterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and... 
IMMUNE CELLS | Immunome | LANDSCAPE | PROGNOSIS | Tertiary lymphoid structures | MACROPHAGES | TISSUE | RECEPTOR | Breast cancer | Neurogenesis | CROSS-TALK | Molecular subtypes | ONCOLOGY | Transcriptomics | Triple-negative | SCHWANN-CELLS | EXPRESSION | TUMOR MICROENVIRONMENT | Care and treatment | Genetic aspects | Immune response | Research | Cell differentiation | Life Sciences | Cancer
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2010, Volume 122, Issue 2, pp. 429 - 437
To assess anti-tumor activity of sequential epirubicin/cyclophosphamide followed by docetaxel with the randomized addition of celecoxib in HER2 negative... 
Neoadjuvant chemotherapy | Oncology | Breast cancer | Celecoxib | Medicine & Public Health | Trastuzumab | SURGICAL ADJUVANT BREAST | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | STAGE-II | PACLITAXEL | TRIAL | PRIMARY SYSTEMIC THERAPY | PREOPERATIVE CHEMOTHERAPY | EPIRUBICIN | ONCOLOGY | COX-2 INHIBITORS | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Antibodies, Monoclonal, Humanized | Time Factors | Adult | Female | Neoadjuvant Therapy | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | France | Neoplasm Invasiveness | In Situ Hybridization, Fluorescence | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Pyrazoles - administration & dosage | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Therapeutics | Neoplasm Staging | Sulfonamides - administration & dosage | Lumpectomy | Care and treatment | Cancer patients | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Angiogenesis inhibitors | Cancer | Antimitotic agents | Chemotherapy | Antineoplastic agents | Index Medicus
Journal Article